You are here

Article Text

Article menu
Download PDFPDF
Adverse drug reactions
Psoriasiform and acneiform lesions in a patient with bipolar disease
  1. Ankur Guliani1,
  2. Tek Chand Yadav2
  1. 1 Dermatology, Civil Hospital, Baddi Distt Solan, Baddi, Himachal Pradesh, India
  2. 2 Internal Medicine, Bhagat Phool Singh, Government Medical College for women Khanpur, Sonipat, Haryana, India
  1. Correspondence to Dr Ankur Guliani, Dermatology, Civil Hospital, Baddi Distt Solan, Baddi 173205, India; gulianiankur502{at}gmail.com

http://dx.doi.org/10.1136/postgradmedj-2018-136329

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A 34-year-old man was referred from psychiatry department with a 4-week history of erythematous scaly lesions over his scalp and upper extremities, with associated acneiform eruptions over the face. Historically, the patient was a diagnosed case of type II bipolar disease, receiving lithium carbonate daily for past 6 months. He was not taking any other medication. Clinical examination revealed well-defined erythematous scaly papules and plaques with white semiadherent scales with mild-to moderate induration over the scalp, chest, back and upper extremities (figures 1 and 2). Additionally, he had skin-coloured to erythematous …

    View Full Text

    Footnotes

    • Contributors AG and TCY had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: AG. Acquisition, analysis and interpretation of data: AG and TCY. Drafting of the manuscript: AG. Critical revision of the manuscript for important intellectual content: AG and TCY.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.